This is a small, likely routine sale of shares acquired 20 months ago on the open market. No signal of insider concern about valuation or upcoming news. Monitor for Form 4 filings confirming the actual sale.
Price Chart
Executive Summary
Francis Knuettel II, an officer of Pelthos Therapeutics Inc. (PTHS), filed a Form 144 on 5/22/2026 indicating intent to sell 1,720 shares of common stock, with an estimated aggregate market value of $46,629.20 based on recent trade prices. The shares were acquired via open-market purchases in September 2024. At a ~$94M market cap, this represents a very small fraction of total shares outstanding and is likely a routine liquidity transaction — the insider is selling shares acquired nearly 20 months ago at market, not options or restricted stock. No earnings or catalyst-driven timing is evident.
Key Facts
- Form 144 filed by officer Francis Knuettel II on 5/22/2026.
- Proposed sale of 1,720 shares of common stock, estimated aggregate value ~$46,629.
- Shares acquired via open-market purchases on 9/10, 9/11, 9/12, and 9/13/2024.
- Shares held in trust account (Lara Knuettel Revocable Trust); sale may be trust-administration related.
- Market cap ~$94M; sale represents minimal relative dilution/insider liquidity event.
Financial Impact
Roughly $46,600 at recent prices; ~0.05% of market cap.
Risk Factors
- Sale is small relative to holdings — no material bearish signal.
- No evidence of impending catalyst or earnings-distress timing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-003914 |
| Document: 0001959173-26-003914-index.html | 0001959173-26-003914 |
| Document: 0001959173-26-003914.txt | 0001959173-26-003914 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 24d ago | 8-K | $20.60 $20.50 | ▼ −0.49% | ▼ −1.65% | $17.01 (−17.43%) |
Aug 13, 2026 10w ago | 8-K | $28.95 $26.66 | ▲ +7.91% | ▲ +5.95% | $17.01 (+41.24%) |
Aug 3, 2026 12w ago | Press Release | $26.84 | awaiting T+5 | — | $17.01 (−36.62%) |
Jun 17, 2026 18w ago | Insider Cluster | $29.00 $29.21 | ▲ +0.72% | ▲ +2.39% | $17.01 (−41.34%) |
May 28, 2026 21w ago | 8-K | $26.47 $25.55 | ▼ −3.48% | ▼ −0.95% | $17.01 (−35.74%) |
May 22, 2026 22w ago | 144 | $26.66 $26.20 | ▼ −1.73% | ▼ −3.40% | $17.01 (−36.20%) |
May 21, 2026 22w ago | 8-K | $26.66 $26.20 | ▲ +1.73% | ▲ +3.38% | $17.01 (+36.20%) |
May 14, 2026 23w ago | 8-K | $27.69 $27.10 | ▼ −2.13% | ▼ −1.41% | $17.01 (−38.57%) |
May 14, 2026 23w ago | Press Release | $27.69 $27.10 | ▼ −2.13% | ▼ −1.41% | $17.01 (−38.57%) |
Apr 20, 2026 26w ago | 3 | $23.00 $24.97 | ▲ +8.57% | ▲ +7.48% | $17.01 (−26.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers